Zelira Therapeutics Limited (ASX:ZLD) announced a private placement of 91,770,000 fully-paid ordinary shares to be issued at a price of AUD 0.05 per share for gross proceeds of AUD 4,588,500 on February 5, 2020. The transaction will include participation Richard Hopkins, Managing Director of the company, for AUD 50,000 and other existing and new investors both domestically and in the United States. The transaction is expected to close on February 10, 2020.